Press Releases
FDA accepts supplemental biologics license application for Roche’s Gazyva/Gazyvaro for treatment of lupus nephritis
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental…
FairJourney Biologics acquires Charles River Laboratories South San Francisco facility
FairJourney Biologics S.A., leaders in the discovery and optimization of antibodies, announced that it had completed the acquisition of the…
Eton announces commercial launch of Galzin (zinc acetate) capsules
Eton Pharmaceuticals, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has…
Fapon Biopharma announces FDA approval of IND for FP008
Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food…
BlueRock Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases
Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, today announced…
Woolsey completes B round extension to advance its ALS programme
Woolsey Pharmaceuticals today announced the successful completion of an extension to its Series B Preferred financing round by existing investors.…
Argobio and the Institut Pasteur launch Enodia Therapeutics: A biotech company with a new approach for Targeted protein Degradation
Argobio and the Institut Pasteur proudly announce the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block…
Fosun Pharma received NMPA approval for Wan Ti Le
Shanghai Fosun Pharmaceutical announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development, has received approval from the National Medical…
Clene and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8’s Impact on NfL Reduction
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage…
GRIN Therapeutics receives FDA breakthrough therapy designation for Radiprodil
GRIN Therapeutics, a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the U.S. Food…